Nafamostat Mesilate
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Nafamostat Mesilate, covering 2013-01-07 to 2025-09-25. Get the full timeline:
Most recent: Clinical Trial Update: Use of Nafamostat Mesilate for Anticoagulation in Patients With ECMO [NA]